Printer friendly
Acronymfinder

What does AGAB stand for?

AGAB stands for Antigen-Antibody


This definition appears very rarely and is found in the following Acronym Finder categories:

  • Science, medicine, engineering, etc.

See other meanings of AGAB

Samples in periodicals archive:

The most frequent positive serologic IgG antigen-antibody complexes found on the food IgG tests were: baker's yeast, 1 7 out of 20 (85%); onion mix, 13 out of 20 (65%); pork, 12 out of 20 (60%); peanut, 12 out of 20 (60%); corn, 11 out of 20 (55%); wheat, 10 out of 20 (50%); soybean, 10 (50%); carrot, 9 out of 20 (45%); cheddar cheese, 8 out of 20 (40%); egg white, 8 out of 20 (40%).
Various buffer compositions, electrophoretic transfer conditions, nitrocellulose pore sizes, "blocking" agents for protein-adsorptive sites on the replica paper, antibody incubation and replica washing conditions, and the substitution of radioiodinated Staphylococcus aureus protein A for second-antibody detection of antigen-antibody complexes by radiography all were assessed in a couple of weeks.
It is assumed that autoimmunity occurs via one of three basic pathways to cause tissue damage in Meniere disease, which may or may not be organ-specific: (1) autoantibodies directed against antigens found upon or within tissue cells, (6-10) (2) circulation and deposition of antigen-antibody complexes with activation of the complement system and resultant inflammatory tissue destruction, (8,10,11) or (3) an inflammatory reaction mediated by sensitized T lymphocytes.
Eleven novel antigen-antibody systems that are specific to rheumatoid arthritis and three that are associated with the disease were identified by applying an autoantibody-profiling procedure based on cDNA phage display to clones of synovial tissue from 92 patients with rheumatoid arthritis (RA), 30 rheumatic controls, and 38 healthy controls, Klaartje Somers reported at the annual meeting of the Federation of Clinical Immunology Societies.
Chapters cover virologic and immunologic characteristics, dynamics of HBV revealed by follow-up studies of NAT-positive donors, immune-based therapy for chronic HBV infection, and experimental and clinical studies of HBV surface antigen-antibody complex therapeutic vaccine.